[1] 曾益新主编.肿瘤学.北京:人民卫生出版社,1999:P59 [2] Ko LD, Prives C.. P53: puzzle and paradign . Genes Development, 1996,10: 1054 [3] 成军编著. 肿瘤相关基因.北京:北京医科大学出版社,2000:P155 [4] Gottlied TM, Oren M.. P53 in growth control and neoplasia. Biochim Biophys Acta, 1996,1287: 77 [5] 杨剑. 细胞组期素D1与肿瘤研究进展.国外医学肿瘤学分册,2003,30(5):336-338 [6] 杨浚霞.DNA修复机制与肿瘤耐药性.国外医学肿瘤学分册,2000,27(6):352-355 [7] 朱峰.胃泌素在恶性肿瘤中的作用机制.中国肿瘤,2003,12(10):590 [8] Kidd M, Tang LH, Modlin IM, etal. Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a mastomys rodent model of gastric neoplasia [J].. Digestion,2000,62(2-3):143-151 [9] 朱晓东,林庚金,钱立平等.生存蛋白在胃癌中的表达及与P53,C-erbB2表达的关系。复旦学报, 2003,30(2):123-126 [10] Miza A ,MCGuirk M, Hockenberry TN,etal. Human surviving is negatively regulated by wide type- P53 and partioipates in P53-dependent apoptotic partway.. On cogene, 2002,21:2613 [11] Ruth LL, John G,Philip JD, et al. Genetic changes associated with telomerase activity in breast can-cer [J].. Int J cancer, 1999,84(5):516-520 [12] 樊听.端粒酶与癌基因的最新研究进展.医学综述,2003,9(10):588-589 [13] 由英,辛杨培.关卡滞留机制中P53的作用.国外医学遗传学分册,1997,20(3):159-160 [14] 杨震.非甾体消炎药抗肿瘤作用研究进展.国外医学肿瘤学分册,2003,30(1):51-52 [15] 柳湘.联合基因治疗肿瘤研究新进展.国外医学肿瘤学分册,2000,27(5):257-259 [16] Bouret M, Ellisl M, Nishizakim, etal. Adenorrus-mediated wide type P53 gene transfer down-regula-tes vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer[J].. cancer Res, 1998,58(1):2288-2292 [17] 张健慧,李琰,王端等.中国人食管癌及肺癌发病风险与P53基因多态性.中国肿瘤杂志,2003, 25(4):365-367 [18] 张伟,林宜先,熊永炎等.伴神经内分泌分化非小细胞肺癌中P53,bcl-2及C-myc的表达.第六届全国肿瘤学术大会论文汇编. 2002:51 [19] 李毅民.癌症易感基因及其所致肿瘤综合征的防治策略.癌变·畸变·突变,2002,14(3):202- 204 [20] 付唆林,郑天荣,潘秀珍等.大肠肿瘤P53蛋白过表达对原位TH1/TH2平衡的影响.中国癌症杂志,2001,11(6):493-499 [21] Dachs GV, Tozer GM. Hypoxia modulated gene expression :angiogenesis, metastasis and therapeutic-exploitation [J].. Eur J cancer, 2000,36(13):1649 [22] Bernal JA, luna R, Espina A, et al. Human securing interacts with P5.. |